C Y Chen A, Sen DR. Hyperactive Dendritc Cells Redirect Aged Antitumor Immunity. Cancer research. 2024;84(19):3130-3131. doi:10.1158/0008-5472.CAN-24-2650PubMedDOIGoogle Scholar
Publications
Hong MM, Froelicher D, Magner R, Popic V, Berger B, Cho H. Secure discovery of genetic relatives across large-scale and distributed genomic data sets. Genome research. 2024. doi:10.1101/gr.279057.124PubMedDOIGoogle Scholar
Schafer DP, Stevens B, Bennett ML, Bennett FC. Role of Microglia in Central Nervous System Development and Plasticity. Cold Spring Harbor perspectives in biology. 2024. doi:10.1101/cshperspect.a041810PubMedDOIGoogle Scholar
Ibrahim S, Bielecki J, Kocabas E, et al. Lifestyle approaches to hypertension for prevention of stroke and vascular cognitive impairment: a realist review protocol. BMJ open. 2024;14(9):e088631. doi:10.1136/bmjopen-2024-088631PubMedDOIGoogle Scholar
Song M, Han Y, Zhao Y, et al. Association of autosomal mosaic chromosomal alterations with risk of bladder cancer in Chinese adults: a prospective cohort study. Cell death & disease. 2024;15(9):706. doi:10.1038/s41419-024-07087-6PubMedDOIGoogle Scholar
Schwabl P, Camponovo F, Clementson C, et al. Contrasting genomic epidemiology between sympatric Plasmodium falciparum and Plasmodium vivax populations. Nature communications. 2024;15(1):8450. doi:10.1038/s41467-024-52545-6PubMedDOIGoogle Scholar
Alban TJ, Riaz N, Parthasarathy P, et al. Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab. Nature medicine. 2024. doi:10.1038/s41591-024-03240-yPubMedDOIGoogle Scholar
Liu S, Zhu J, Zhong H, et al. Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations. Diabetologia. 2024. doi:10.1007/s00125-024-06277-3PubMedDOIGoogle Scholar
Park S, Kim S, Kim B, et al. Multivariate genomic analysis of 5 million people elucidates the genetic architecture of shared components of the metabolic syndrome. Nature genetics. 2024. doi:10.1038/s41588-024-01933-1PubMedDOIGoogle Scholar
Medford AJ, Carmeli AB, Ritchie A, et al. A standing platform for cancer drug development using ctDNA-based evidence of recurrence. Nature reviews. Cancer. 2024. doi:10.1038/s41568-024-00742-2PubMedDOIGoogle Scholar